Clinical Trial Update: A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION) [NA]

View source ↗

Summary

A completed multicenter, open-label, prospective non-randomized study of INCRAFT for abdominal aortic aneurysms has posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• INCRAFT

Snippet

Sponsor: Cordis US Corp. | Conditions: Abdominal Aortic Aneurysms | NA | Status: COMPLETED | Results posted: 2013-11-26